Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Clin Cancer Res. 2009 Feb 24;15(5):1645–1654. doi: 10.1158/1078-0432.CCR-08-2581

Fig. 5.

Fig. 5

Relations of Bcl-2 expression to other prognostic indicators did not account for the observed relation between Bcl-2 and recurrence. Restricting analysis to male patients (A), patients with N score of 2 (B), or disease stage IV (C) resulted in similar relations between pretreatment Bcl-2 status and recurrence.